These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 31581940

  • 1. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L, Braaten T, Al-Shibli K, Lund E, Busund LR.
    J Transl Med; 2019 Oct 03; 17(1):334. PubMed ID: 31581940
    [Abstract] [Full Text] [Related]

  • 2. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y, Noyan S, Aydos A, Gur Dedeoglu B.
    OMICS; 2018 Nov 03; 22(11):709-716. PubMed ID: 30388053
    [Abstract] [Full Text] [Related]

  • 3. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
    Kunc M, Popęda M, Niemira M, Szałkowska A, Bieńkowski M, Pęksa R, Łacko A, Radecka BS, Braun M, Pikiel J, Litwiniuk M, Pogoda K, Iżycka-Świeszewska E, Krętowski A, Żaczek AJ, Biernat W, Senkus-Konefka E.
    Diagnostics (Basel); 2020 Aug 20; 10(9):. PubMed ID: 32825530
    [Abstract] [Full Text] [Related]

  • 4. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.
    PLoS One; 2014 Aug 20; 9(1):e87032. PubMed ID: 24498016
    [Abstract] [Full Text] [Related]

  • 5. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
    Sakurai M, Masuda M, Miki Y, Hirakawa H, Suzuki T, Sasano H.
    Int J Biol Markers; 2015 May 26; 30(2):e190-9. PubMed ID: 25907662
    [Abstract] [Full Text] [Related]

  • 6. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
    Leivonen SK, Sahlberg KK, Mäkelä R, Due EU, Kallioniemi O, Børresen-Dale AL, Perälä M.
    Mol Oncol; 2014 Feb 26; 8(1):93-104. PubMed ID: 24148764
    [Abstract] [Full Text] [Related]

  • 7. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T, McKnight B, Rosati R, Kim S, Huang Y, Viola-Villegas N, Ratnam M.
    J Biol Chem; 2018 Jan 26; 293(4):1163-1177. PubMed ID: 29162724
    [Abstract] [Full Text] [Related]

  • 8. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 26; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.
    Breast Cancer Res; 2009 May 26; 11(3):R27. PubMed ID: 19432961
    [Abstract] [Full Text] [Related]

  • 10. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes.
    Li JY, Jia S, Zhang WH, Zhang Y, Kang Y, Li PS.
    Asian Pac J Cancer Prev; 2013 May 26; 14(5):3197-203. PubMed ID: 23803104
    [Abstract] [Full Text] [Related]

  • 11. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 26; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 12. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
    Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H.
    Endocr Relat Cancer; 2013 Feb 26; 20(1):91-102. PubMed ID: 23183268
    [Abstract] [Full Text] [Related]

  • 13. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 26; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 14. Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p.
    Calvano Filho CM, Calvano-Mendes DC, Carvalho KC, Maciel GA, Ricci MD, Torres AP, Filassi JR, Baracat EC.
    Tumour Biol; 2014 Aug 26; 35(8):7733-41. PubMed ID: 24810926
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A, Shai A, Ashkenazi I, Sarid LA, Drobot A, Bickel A, Shomron N.
    Oncotarget; 2017 Apr 18; 8(16):25963-25976. PubMed ID: 28404930
    [Abstract] [Full Text] [Related]

  • 16. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 18; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

  • 17. miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
    Rinnerthaler G, Hackl H, Gampenrieder SP, Hamacher F, Hufnagl C, Hauser-Kronberger C, Zehentmayr F, Fastner G, Sedlmayer F, Mlineritsch B, Greil R.
    Int J Mol Sci; 2016 Jan 26; 17(2):. PubMed ID: 26821018
    [Abstract] [Full Text] [Related]

  • 18. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF, Oliveira RJ, O Silva VA, D C Vieira RA, Reis RM, C Marques MM.
    BMC Cancer; 2021 Jan 18; 21(1):76. PubMed ID: 33461524
    [Abstract] [Full Text] [Related]

  • 19. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    Johannessen C, Moi L, Kiselev Y, Pedersen MI, Dalen SM, Braaten T, Busund LT.
    PLoS One; 2017 Jan 18; 12(10):e0186658. PubMed ID: 29073169
    [Abstract] [Full Text] [Related]

  • 20. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY, Kuo WH, Hung JH, Lee CY, Lee YH, Chang YC, Lin WC, Shen CY, Huang CS, Hsieh FJ, Lai LC, Tsai MH, Chang KJ, Chuang EY.
    Mol Cancer; 2015 Feb 10; 14():36. PubMed ID: 25888956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.